小智港股覆盤 | 12月13日
今日,港股三大指數集體上漲。截止收盤,恆生指數漲0.68%,報19596點。國企指數漲0.4%,報6654點。恆生科技指數漲0.73%,報4223點。市場約889只個股上漲,794只個股下跌。成交額突破1240.88億港幣,和昨天同期相比下跌21.83%。南下資金淨流入16.61億港幣。

盤面上,餐飲酒店板塊漲幅較前。金粵控股漲超52%;TOPSTANDARDCORP漲超20%;OKURA HOLDINGS、譚仔國際等多股漲超14%;泛海酒店漲超12%。

海運板塊跟隨走強。海豐國際漲超5%;珠江船務、永豐集團控股、象興國際等多股漲超4%;東方海外國際漲超2%。

公路鐵路板塊走高。冠忠巴士集團漲超13%;載通漲超5%;德銀天下漲超4%;港鐵公司漲超2%。

互聯網醫療板塊跌幅居前。平安好醫生跌超8%;阿裏健康跌超4%。平安好醫生早盤漲超7%領漲互聯網醫療,聯防聯控機制提出做好新冠肺炎互聯網醫療服務;恆生指數高開0.17%報19484點,阿裏健康漲2.54%。

百貨零售板塊走低。歲寶百貨、名創優品等多股跌超6%。光大證券首予名創優品“買入”評級,目標價25港元。

製藥板塊走低。賽生藥業跌超11%;康希諾生物跌超6%;四環醫藥、翰森製藥等多股跌超5%;凱萊英跌超4%。賽生藥業漲超17%,那西妥單抗獲國家藥監局批準,機構看好公司主業盈利能力。

uSMART智能寫手的信息、數據均來自媒體公開報道,智能寫手不能保證其完全準確,內容僅供參考,不構成投資建議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.